Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines.
作者信息
Avelino-Silva Vivian Iida, Barros Filho Mario Thadeu Leme de
机构信息
Faculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
出版信息
Einstein (Sao Paulo). 2022 Jan 5;19:eED6840. doi: 10.31744/einstein_journal/2021ED6840.
Abstract
摘要
相似文献
1
Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines.医疗保健领域新技术评估——药物的超说明书使用以及新冠疫苗的实施与分配伦理
Einstein (Sao Paulo). 2022 Jan 5;19:eED6840. doi: 10.31744/einstein_journal/2021ED6840.
2
Safety Consequences of Off-Label Drugs Used for COVID-19.用于治疗新冠肺炎的超说明书用药的安全性后果。
Drug Saf. 2021 Apr;44(4):399-402. doi: 10.1007/s40264-021-01056-0. Epub 2021 Mar 5.
3
Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations.儿科超说明书使用新冠病毒疫苗：伦理与法律考量。
Hastings Cent Rep. 2021 Nov;51(6):27-32. doi: 10.1002/hast.1296. Epub 2021 Nov 8.
4
Recent Advances on Drugs and Vaccines for COVID-19.新冠病毒药物和疫苗的最新进展
Inquiry. 2021 Jan-Dec;58:469580211055630. doi: 10.1177/00469580211055630.
5
Assessment of Awareness and Experience of Using off-label Drugs by Doctors of Clinical Specialties.临床专科医生对超说明书用药的认知和使用情况的评估。
Kardiologiia. 2021 May 31;61(5):41-50. doi: 10.18087/cardio.2021.5.n1510.
6
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.信使 RNA 新冠病毒 2019 疾病（COVID-19）疫苗对医护人员队列中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的有效性。
Clin Infect Dis. 2021 Sep 15;73(6):e1376-e1379. doi: 10.1093/cid/ciab361.
7
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.SARS-CoV-2 疫苗的快速开发：拯救世界的疫苗。
Front Immunol. 2022 Oct 3;13:961198. doi: 10.3389/fimmu.2022.961198. eCollection 2022.
8
Therapeutic Agents Against COVID-19 with Clinical Evidence.抗 COVID-19 的治疗药物：临床证据。
Curr Pharm Des. 2021;27(13):1608-1617. doi: 10.2174/1381612827666210114150951.
9
Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体时代医护人员的新冠病毒病（COVID-19）强制接种疫苗。
Vaccine. 2022 Nov 28;40(50):7167-7169. doi: 10.1016/j.vaccine.2022.10.053. Epub 2022 Oct 26.
10
Why we still need drugs for COVID-19 and can't just rely on vaccines.为什么我们仍然需要治疗新冠病毒的药物，而不能仅仅依赖疫苗。
Respirology. 2022 Feb;27(2):109-111. doi: 10.1111/resp.14199. Epub 2021 Dec 30.
引用本文的文献
1
Development of a mobile application for health education about sepsis.开发一款关于脓毒症健康教育的移动应用程序。
Rev Esc Enferm USP. 2023 Jun 5;57:e20220269. doi: 10.1590/1980-220X-REEUSP-2022-0269en. eCollection 2023.
本文引用的文献
1
Cost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries.新冠肺炎疫苗在中低收入国家的成本效益分析。
J Infect Dis. 2022 Nov 28;226(11):1887-1896. doi: 10.1093/infdis/jiac243.
2
COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling.巴西圣保罗队列研究中的 COVID-19 和艾滋病病毒/艾滋病：按种族和受教育程度划分的结局和差异。
AIDS Care. 2022 Jul;34(7):832-838. doi: 10.1080/09540121.2021.1936444. Epub 2021 Jun 4.
3
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.辉瑞-BioNTech 新冠疫苗在青少年中的安全性、免疫原性和有效性。
N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.
4
A global database of COVID-19 vaccinations.一个全球 COVID-19 疫苗接种数据库。
Nat Hum Behav. 2021 Jul;5(7):947-953. doi: 10.1038/s41562-021-01122-8. Epub 2021 May 10.
5
Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany.关于新冠病毒自愿和强制接种疫苗的态度：来自德国的证据。
PLoS One. 2021 May 10;16(5):e0248372. doi: 10.1371/journal.pone.0248372. eCollection 2021.
6
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.辉瑞-生物科技和莫德纳疫苗对≥65 岁住院成年人 COVID-19 的有效性-美国，2021 年 1 月至 3 月。
MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):674-679. doi: 10.15585/mmwr.mm7018e1.
7
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants.加快疫苗接种对于减轻高传染性的新冠病毒变异毒株的影响至关重要。
EClinicalMedicine. 2021 May;35:100865. doi: 10.1016/j.eclinm.2021.100865. Epub 2021 Apr 25.
8
Review the safety of Covid-19 mRNA vaccines: a review.新冠病毒信使核糖核酸疫苗安全性综述：一篇综述
Patient Saf Surg. 2021 May 1;15(1):20. doi: 10.1186/s13037-021-00291-9.
9
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.英国COVID症状研究应用程序使用者接种疫苗后的疫苗副作用和SARS-CoV-2感染：一项前瞻性观察研究。
Lancet Infect Dis. 2021 Jul;21(7):939-949. doi: 10.1016/S1473-3099(21)00224-3. Epub 2021 Apr 27.
10
Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil.巴西圣保罗市低收入和非裔人群感染 COVID-19 死亡率更高。
BMJ Glob Health. 2021 Apr;6(4). doi: 10.1136/bmjgh-2021-004959.
Zotero 插件